PADI4 and rheumatoid arthritis: Indeed, ~30% of RA patient, but not control sera, were found to be anti‐PAD4 positive, with anti‐PAD4 positivity occurring prior to (clinical) disease onset and being a marker of severe disease [124, 125, 126.